Detalhe da pesquisa
1.
Topical therapy for regression and melanoma prevention of congenital giant nevi.
Cell
; 185(12): 2071-2085.e12, 2022 06 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35561684
Mostrar mais
Texto completo
Documentos relacionados
2.
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.
Nat Immunol
; 22(7): 851-864, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34099918
3.
An Acquired Vulnerability of Drug-Resistant Melanoma with Therapeutic Potential.
Cell
; 173(6): 1413-1425.e14, 2018 05 31.
Artigo
Inglês
| MEDLINE | ID: mdl-29754815
4.
Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle.
Nat Immunol
; 20(2): 206-217, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30664764
5.
Hedgehog Pathway Inhibition.
Cell
; 164(5): 831, 2016 Feb 25.
Artigo
Inglês
| MEDLINE | ID: mdl-26919418
6.
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.
Cell
; 167(2): 397-404.e9, 2016 Oct 06.
Artigo
Inglês
| MEDLINE | ID: mdl-27667683
8.
TGF-ß promotes heterogeneity and drug resistance in squamous cell carcinoma.
Cell
; 160(5): 963-976, 2015 Feb 26.
Artigo
Inglês
| MEDLINE | ID: mdl-25723170
9.
Broad-spectrum therapeutic suppression of metastatic melanoma through nuclear hormone receptor activation.
Cell
; 156(5): 986-1001, 2014 Feb 27.
Artigo
Inglês
| MEDLINE | ID: mdl-24581497
10.
RHOJ controls EMT-associated resistance to chemotherapy.
Nature
; 616(7955): 168-175, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36949199
11.
Pharmacological targeting of netrin-1 inhibits EMT in cancer.
Nature
; 620(7973): 402-408, 2023 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-37532929
12.
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.
Nature
; 606(7915): 797-803, 2022 06.
Artigo
Inglês
| MEDLINE | ID: mdl-35705814
13.
Femtosecond pulsed laser photodynamic therapy activates melanin and eradicates malignant melanoma.
Proc Natl Acad Sci U S A
; 121(14): e2316303121, 2024 Apr 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38551838
14.
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
N Engl J Med
; 388(9): 813-823, 2023 Mar 02.
Artigo
Inglês
| MEDLINE | ID: mdl-36856617
15.
Outcomes and characteristics of nonmelanoma skin cancers in patients with myeloproliferative neoplasms on ruxolitinib.
Blood
; 143(2): 178-182, 2024 Jan 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37963262
16.
The Dietary Supplement Chondroitin-4-Sulfate Exhibits Oncogene-Specific Pro-tumor Effects on BRAF V600E Melanoma Cells.
Mol Cell
; 69(6): 923-937.e8, 2018 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-29547721
17.
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Lancet
; 403(10427): 632-644, 2024 Feb 17.
Artigo
Inglês
| MEDLINE | ID: mdl-38246194
18.
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.
N Engl J Med
; 387(17): 1557-1568, 2022 10 27.
Artigo
Inglês
| MEDLINE | ID: mdl-36094839
19.
Integrating novel agents into the treatment of advanced mycosis fungoides and Sézary syndrome.
Blood
; 141(7): 695-703, 2023 02 16.
Artigo
Inglês
| MEDLINE | ID: mdl-36379025
20.
Dimethyl fumarate treatment in relapsed and refractory cutaneous T-cell lymphoma: a multicenter phase 2 study.
Blood
; 142(9): 794-805, 2023 08 31.
Artigo
Inglês
| MEDLINE | ID: mdl-37217183
